- Home
- RCMT vs SGHT Comparison
RCMT vs SGHT Comparison
Compare RCMT & SGHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCMT
- SGHT
- Stock Information
- Founded
- RCMT 1971
- SGHT 2011
- Country
- RCMT United States
- SGHT United States
- Employees
- RCMT N/A
- SGHT N/A
- Industry
- RCMT Professional Services
- SGHT Medical Specialities
- Sector
- RCMT Consumer Discretionary
- SGHT Health Care
- Exchange
- RCMT Nasdaq
- SGHT Nasdaq
- Market Cap
- RCMT 200.2M
- SGHT 193.2M
- IPO Year
- RCMT N/A
- SGHT 2021
- Fundamental
- Price
- RCMT $22.65
- SGHT $5.04
- Analyst Decision
- RCMT Strong Buy
- SGHT Buy
- Analyst Count
- RCMT 2
- SGHT 8
- Target Price
- RCMT $33.50
- SGHT $4.50
- AVG Volume (30 Days)
- RCMT 31.2K
- SGHT 226.8K
- Earning Date
- RCMT 11-05-2025
- SGHT 11-06-2025
- Dividend Yield
- RCMT N/A
- SGHT N/A
- EPS Growth
- RCMT N/A
- SGHT N/A
- EPS
- RCMT 1.76
- SGHT N/A
- Revenue
- RCMT $299,916,000.00
- SGHT $76,303,000.00
- Revenue This Year
- RCMT $15.03
- SGHT N/A
- Revenue Next Year
- RCMT $7.49
- SGHT $12.04
- P/E Ratio
- RCMT $12.83
- SGHT N/A
- Revenue Growth
- RCMT 11.01
- SGHT N/A
- 52 Week Low
- RCMT $13.18
- SGHT $2.03
- 52 Week High
- RCMT $28.27
- SGHT $5.48
- Technical
- Relative Strength Index (RSI)
- RCMT 38.15
- SGHT 73.46
- Support Level
- RCMT $22.46
- SGHT $4.87
- Resistance Level
- RCMT $23.67
- SGHT $5.31
- Average True Range (ATR)
- RCMT 0.83
- SGHT 0.32
- MACD
- RCMT -0.01
- SGHT 0.14
- Stochastic Oscillator
- RCMT 42.39
- SGHT 91.58
About RCMT RCM Technologies Inc.
RCM Technologies Inc is a provider of business and technology solutions designed to enhance and maximize the operational performance of its customers. It operates in three segments: Specialty Health Care, Engineering, and Life Sciences, Data and Solutions (LS&D). The company generates maximum revenue from the Specialty Health Care segment that provides staffing solutions including medical healthcare professionals, health information management professionals, nurses, paraprofessionals, physicians, and therapists. Geographically, it derives a majority of its revenue from the United States and also has a presence in Canada, Puerto Rico, the Philippines, and Europe.
About SGHT Sight Sciences Inc.
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.